Guido a very honest explanation and I agree that the Board has always stated that all was well as the science behind all the projects were very good.
Science or not we have failed, and the easy excuse was that this is typical in the biotech world.
When all failed, nobody said that the university research of decades was in fact trashed in the bin in a day and that the all science was just very poor.
The whole has been a disaster and the old board and the new board being in the chair share the full responsibility for all this failure.
Now we sit on shares with no value and get informed that all the Board work hard for a future of a shell.
The reassurance that was given even before when they stated that all was well, to be serene for the outcome, as this is hard science and there are the best people in the game seating in FTT.
- Forums
- ASX - By Stock
- DLM
- Ann: Appendix 4D and Half Year Report to 30 June 2019
Ann: Appendix 4D and Half Year Report to 30 June 2019, page-10
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online